×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [24]
复旦大学上海医学院 [6]
合肥物质科学研究院 [6]
厦门大学 [4]
过程工程研究所 [4]
高能物理研究所 [3]
更多...
内容类型
期刊论文 [65]
学位论文 [2]
发表日期
2022 [2]
2021 [4]
2020 [4]
2019 [8]
2018 [13]
2017 [10]
更多...
学科主题
Biochemist... [1]
Cell Biolo... [1]
Engineerin... [1]
Oncology [1]
Science & ... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共67条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
GPR30 Activation Promotes the Progression of Gastric Cancer and Plays a Significant Role in the Anti-GC Effect of Huaier
期刊论文
JOURNAL OF ONCOLOGY, 2022, 卷号: 2022
作者:
Wang, Xiao-feng
;
Hu, Can
;
Mo, Shao-Wei
;
Xu, Jing-Li
;
Liu, Yan
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/05/16
IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation
期刊论文
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022, 卷号: 22
作者:
Xu, Yipeng
;
Pachnikova, Gabriela
;
Wang, He
;
Wu, Yaoyao
;
Przybilla, Dorothea
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2022/12/23
IC50
docetaxel
spheroids
drug testing
preclinical models
prostate cancer
2D clinical models
3D clinical models
cell culture
A novel PDX modeling strategy and its application in metabolomics study for malignant pleural mesothelioma
期刊论文
BMC CANCER, 2021, 卷号: 21
作者:
Chen, Zhongjian
;
Yang, Chenxi
;
Guo, Zhenying
;
Song, Siyu
;
Gao, Yun
收藏
  |  
浏览/下载:48/0
  |  
提交时间:2022/01/10
Patient-derived xenograft
Malignant pleural mesothelioma
GC-MS
Metabolomics
Ultrasound-guided biopsy
Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
期刊论文
CELL DEATH & DISEASE, 2021, 卷号: 12
作者:
Liu, Dongyan
;
Hou, Xiaonan
;
Wu, Wangyu
;
Zafagnin, Valentina
;
Li, Yunjian
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2021/09/06
SAF-248, a novel PI3K delta-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma
期刊论文
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 11
作者:
Zhang, Xi
;
Duan, Yu-ting
;
Wang, Yi
;
Zhao, Xing-dong
;
Sun, Yi-ming
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2021/05/24
PI3Kδ
PI3K
AKT
mTOR
diffuse large B-cell lymphoma
resistance
combination therapy
Tumor Exosomes Reprogrammed by Low pH Are Efficient Targeting Vehicles for Smart Drug Delivery and Personalized Therapy against their Homologous Tumor
期刊论文
ADVANCED SCIENCE, 2021, 页码: 13
作者:
Gong, Changguo
;
Zhang, Xiao
;
Shi, Min
;
Li, Feng
;
Wang, Shuang
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2021/08/31
combination therapy
lipids rearrangement
low pH reprogramming
patient‐
derived xenografts
tumor exosomes
The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
期刊论文
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 卷号: 39
作者:
Ma, Liying
;
Bian, Xing
;
Lin, Wenchu
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2020/11/30
SCLC
PI3K
HDAC
CUDC-907
PARP1
Olaparib
DSB repair
Combination treatment
Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen
期刊论文
NATURE BIOMEDICAL ENGINEERING, 2020, 页码: 19
作者:
Xie, Xiaoling
;
Hu, Yuxing
;
Ye, Tong
;
Chen, Yiran
;
Zhou, Lijuan
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2021/03/29
SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 7
作者:
Xia, Zong-jun
;
Ji, Yin-chun
;
Sun, De-qiao
;
Peng, Xia
;
Gao, Ying-lei
收藏
  |  
浏览/下载:75/0
  |  
提交时间:2020/12/21
ROS1 kinase
ROS1 inhibitor
SAF-189s
lorlatinib
crizotinib resistance
G2032R mutant
NSCLC
Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway
期刊论文
ACTA PHARMACOLOGICA SINICA, 2020
作者:
Chen, Cheng
;
Cheng, Chuan-dong
;
Wu, Hong
;
Wang, Zuo-wei
;
Wang, Li
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2020/11/26
glioblastoma
osimertinib
temozolamide
MAPK-signaling pathway
MNK
eukaryotic translation initiation factor 4E
©版权所有 ©2017 CSpace - Powered by
CSpace